New treatment options for diarrhea syndrome in the clinic of internal diseases
Journal Title: Сучасна гастроентерологія - Year 2019, Vol 0, Issue 2
Abstract
Acute and chronic diarrhea are severe clinical syndromes that can be observed in various diseases of internal organs. The unidentified cause of diarrhea syndrome hampers administration of the etiotropic therapy. The effective and timely treatment promotes the improvement of quality of life and prevents complications’ development. Smectalia is a new form of diosmectite, an antidiarrheal drug used to treat infectious and inflammatory bowel diseases, as well as diarrheal syndrome of various etiologies. Owing to its spatial structure and high plastic viscosity, diosmectite possesses a high enveloping capacity along the gastrointestinal mucosa. By interacting with mucosal glycoproteins, it increases the mucus layer thickness, mucin viscosity and decrease its solubility, restores the mucosa cytoprotective properties, thus raising its resistance to the effects of damaging factors (bile acids, free radicals, bacterial toxins). Diosmectite binds some of the bacterial and viral toxins that is believed to be a promoter for its antidiarrhea effects. There were some evidence-based clinical reports about the diosmectite effects on from the diarrhea in patients with the inflammatory intestinal diseases. Thus, it reduced diarrhea induced by endogenous agents, especially inflammatory cytokines or other factors, including at the inflammatory intestinal diseases. The literature reports the effective use of the dioctahedral smectite for the treatment of diarrhea at the endocrine pathology, and diarrhea resulting from radiotherapy, chemotherapy and procalcitonin acquired immunodeficiency syndrome. The understanding of the antidiarrheal diosmectite effects can open new possibilities for the treatment of acute and chronic diarrhea in the internal medicine clinic.
Authors and Affiliations
G. D. Fadieienko, T. A. Solomentseva
Keywords
Related Articles
- EP ID EP575020
- DOI 10.30978/MG-2019-2-39
- Views 157
- Downloads 0
Complex treatment of non-alcoholic fatty liver disease: experience of the use of hepatoprotectors
Objective — to evaluate the complex therapy effects at the levels of cytokeratin (CK)-18, fibroblast growth factor (FGF)-21 and metabolic parameters of nonalcoholic fatty liver disease (NAFLD) patients. Materials and...
A clinical case of eosinophilic esophagitis combined with macroamylasemia
Eosinophilic esophagitis is one of the most prevalent esophageal diseases and the leading cause of dysphagia and food impaction in children and young adults. The authors presented a clinical case of a patient with eosino...
The use of proton pump inhibitors in the general clinical practice: advantages and disadvantages
The article presents modern views on the use of proton pump inhibitors in clinical practice with account of the patients’ age, therapyduration and comorbidity. The analysis has been performed for the literature data and...
Personal and situational anxiety in young patients with the combined course of gastroesophageal reflux disease and autoimmune thyroiditis
Objective — to assess the psychoemotional status of young patients with gastroesophageal reflux disease (GERD) associated with autoimmune thyroiditis (AIT). Materials and methods. The examinations involved 57 students w...
Peculiarities of microbic landscape at NSAID-induced gastropathy in patients with diabetes mellitus
Objective — to investigate the frequency and nature of microbial lesions of the mucous membrane of the upper gastrointestinal tract in patients with NSAID-induced gastropathy against the background of diabetes mellitus (...